155 related articles for article (PubMed ID: 26819747)
1. Risk of major bleeding at different PT-INR ranges in elderly Japanese patients with non-valvular atrial fibrillation receiving warfarin: a nested case-control study.
Ohgushi A; Ohtani T; Nakayama N; Asai S; Ishii Y; Namiki A; Akazawa M; Echizen H
J Pharm Health Care Sci; 2016; 2():2. PubMed ID: 26819747
[TBL] [Abstract][Full Text] [Related]
2. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
Hirano T; Kaneko H; Mishina S; Wang F; Morita S
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: a single-center observational study.
Naganuma M; Shiga T; Sato K; Murasaki K; Hashiguchi M; Mochizuki M; Hagiwara N
Thromb Res; 2012 Jul; 130(1):21-6. PubMed ID: 22137743
[TBL] [Abstract][Full Text] [Related]
4. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation.
Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M;
Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222
[TBL] [Abstract][Full Text] [Related]
5. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
[TBL] [Abstract][Full Text] [Related]
6. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients.
Lackner TE; Battis GN
Arch Fam Med; 1995 Dec; 4(12):1017-26. PubMed ID: 7496550
[TBL] [Abstract][Full Text] [Related]
7. Optimal INR level in elderly and non-elderly patients with atrial fibrillation receiving warfarin: a report from the COOL-AF nationwide registry in Thailand.
Krittayaphong R; Kunjara-Na-Ayudhya R; Ngamjanyaporn P; Boonyaratavej S; Komoltri C; Yindeengam A; Sritara P; Lip GYH; For The Cool-Af Investigators
J Geriatr Cardiol; 2020 Oct; 17(10):612-620. PubMed ID: 33224180
[TBL] [Abstract][Full Text] [Related]
8. Patient factors against stable control of warfarin therapy for Japanese non-valvular atrial fibrillation patients.
Tomita H; Kadokami T; Momii H; Kawamura N; Yoshida M; Inou T; Fukuizumi Y; Usui M; Funakoshi K; Yamada S; Aomori T; Yamamoto K; Uno T; Ando S;
Thromb Res; 2013 Nov; 132(5):537-42. PubMed ID: 24071466
[TBL] [Abstract][Full Text] [Related]
9. Meta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation.
Kang F; Ma Y; Cai A; Cheng X; Liu P; Kuang J; Mai Z; Mai W
Am J Cardiol; 2021 Mar; 142():74-82. PubMed ID: 33307015
[TBL] [Abstract][Full Text] [Related]
10. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
[TBL] [Abstract][Full Text] [Related]
11. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
12. Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study.
Kawai M; Harada M; Motoike Y; Koshikawa M; Ichikawa T; Watanabe E; Ozaki Y
Int J Cardiol Heart Vasc; 2019 Mar; 22():111-116. PubMed ID: 30705936
[TBL] [Abstract][Full Text] [Related]
13. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
Yasaka M; Minematsu K; Yamaguchi T
Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
[TBL] [Abstract][Full Text] [Related]
14. Optimal INR level in patients with atrial fibrillation with EHRA type 2 valvular heart disease receiving warfarin.
Luengsupabul S; Methavigul K; Methavigul R
J Arrhythm; 2020 Jun; 36(3):425-429. PubMed ID: 32528567
[TBL] [Abstract][Full Text] [Related]
15. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.
Inoue H; Okumura K; Atarashi H; Yamashita T; Origasa H; Kumagai N; Sakurai M; Kawamura Y; Kubota I; Matsumoto K; Kaneko Y; Ogawa S; Aizawa Y; Chinushi M; Kodama I; Watanabe E; Koretsune Y; Okuyama Y; Shimizu A; Igawa O; Bando S; Fukatani M; Saikawa T; Chishaki A;
Circ J; 2013; 77(9):2264-70. PubMed ID: 23708863
[TBL] [Abstract][Full Text] [Related]
16. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation.
Yasaka M; Yamaguchi T
CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034
[TBL] [Abstract][Full Text] [Related]
17. INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation.
Chung JE; Choi YR; Seong JM; La HO; Gwak HS
Int J Clin Pharm; 2015 Dec; 37(6):1038-46. PubMed ID: 26068570
[TBL] [Abstract][Full Text] [Related]
18. [A Retrospective Evaluation of the Impact of Multi-disciplinary Approach for Improving the Quality of Anticoagulation Therapy in Ambulatory Patients with Non-valvular Atrial Fibrillation Receiving Warfarin].
Ohgushi A; Nakayama N; Namiki A; Nagashima A; Ogawa R; Akazawa M; Echizen H
Yakugaku Zasshi; 2019; 139(9):1177-1183. PubMed ID: 31474634
[TBL] [Abstract][Full Text] [Related]
19. Renal Dysfunction Affects Anticoagulation Control With Warfarin and Outcomes in Japanese Elderly Patients With Non-Valvular Atrial Fibrillation.
Inoue H; Kodani E; Atarashi H; Okumura K; Yamashita T; Origasa H;
Circ J; 2018 Aug; 82(9):2277-2283. PubMed ID: 29984788
[TBL] [Abstract][Full Text] [Related]
20. Relationship between aging and dosage of warfarin: the current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine.
Miura T; Nishinaka T; Terada T; Yonezawa K
J Cardiol; 2009 Jun; 53(3):355-60. PubMed ID: 19477376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
